These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4355957)

  • 1. Conversion of hydrocortisone to estrogen in carcinoma of the breast after oophorectomy and adrenalectomy.
    Stonesifer GL; Lowe RH; Cameron JL; Ganis FM
    Ann Surg; 1973 Nov; 178(5):563-4. PubMed ID: 4355957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conversion of (4-14C)-cortisol to (14C)-11beta-hydroxyestradiol in a patient with metastatic breast carcinoma--cortisol metabolism and breast cancer.
    Ganis FM; Lowe RH; Morris MH; Migeon CJ; Stonesifer GL
    J Steroid Biochem; 1974 Oct; 5(6):543-9. PubMed ID: 4427450
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypophysectomy in the treatment of disseminated carcinoma of the breast and prostate gland.
    Tindall GT; Ambrose SS; Christy JH; Patton JM
    South Med J; 1976 May; 69(5):579-83. PubMed ID: 1273614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma hormone responses to tamoxifen therapy and oophorectomy.
    Al-Jurf AS
    J Surg Oncol; 1982 Dec; 21(4):271-3. PubMed ID: 6292582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prediction of hormonal dependency of mammary cancer.
    Block GE; Jensen EV; Polley TZ
    Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assay for human breast cancer hormone responsiveness. A study of 25 cases with clinical correlation.
    Burstein NA; Carey RW
    Oncology; 1974; 29(6):470-83. PubMed ID: 4373689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo uptake of tritiated estradiol in carcinoma of the breast.
    Viladiu P
    Surg Gynecol Obstet; 1975 Apr; 140(4):544-6. PubMed ID: 165580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tonsillar metastasis from carcinoma of the breast with ultrastructural and steroid receptor analyses.
    Barton TK; Kesterson GH; Wellman D; McCarty KS
    Laryngoscope; 1980 Mar; 90(3):477-85. PubMed ID: 6244468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aminoglutethimide on delta 5-androstenediol metabolism in postmenopausal women with breast cancer.
    Bird CE; Masters V; Sterns EE; Clark AF
    Cancer Res; 1982 Nov; 42(11):4797-800. PubMed ID: 6290048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH; Manni A; Arafah BM
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELECTIVE CRITERIA FOR SURGICAL REMOVAL OF THE ENDOCRINE GLANDS IN ADVANCED BREAST CANCER.
    FAIRGRIEVE J
    Surg Gynecol Obstet; 1965 Feb; 120():371-85. PubMed ID: 14257953
    [No Abstract]   [Full Text] [Related]  

  • 14. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible retention of the estrogen-binding capacity after endocrine ablation therapy in the rat and human breast cancer.
    Nomura Y; Abe Y; Yamagata J; Takenaka K
    Gan; 1976 Feb; 67(1):101-4. PubMed ID: 178562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral adrenalectomy for metastatic breast carcinoma.
    Brown PW; Terz JJ; King R; Lawrence W
    Arch Surg; 1975 Jan; 110(1):77-81. PubMed ID: 46746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
    Santen RJ; Worgul TJ; Samojlik E; Interrante A; Boucher AE; Lipton A; Harvey HA; White DS; Smart E; Cox C; Wells SA
    N Engl J Med; 1981 Sep; 305(10):545-51. PubMed ID: 7019703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablative procedures in patients with metastatic breast carcinoma.
    Wells SA; Santen RJ
    Cancer; 1984 Feb; 53(3 Suppl):762-5. PubMed ID: 6362827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of the male breast.
    Wilson ND
    Am Surg; 1968 Jul; 34(7):524-7. PubMed ID: 4172636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.